Molecular signature associated with cladribine treatment in patients with multiple sclerosis

IntroductionLittle is known about the molecular profiling associated with the effect of cladribine in patients with multiple sclerosis (MS). Here, we aimed first to characterize the transcriptomic and proteomic profiles induced by cladribine in blood cells, and second to identify potential treatment...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Nicolas Fissolo, Laura Calvo-Barreiro, Herena Eixarch, Ursula Boschert, Luisa M. Villar, Lucienne Costa-Frossard, Mireia Ferrer, Alex Sanchez, Eva Borràs, Eduard Sabidó, Carmen Espejo, Xavier Montalban, Manuel Comabella
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Frontiers Media S.A. 2023-07-01
Cyfres:	Frontiers in Immunology
Pynciau:	multiple sclerosis cladribine biomarkers omics bioinformatics
Mynediad Ar-lein:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1233546/full
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!